Spots Global Cancer Trial Database for An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck
Official Title: An International Expanded Access Clinical Programme With ZD1839 (IRESSA) for Patients With Advanced Non-small Cell Lung Cancer(NSCLC) and Patients With Recurrent or Metastatic or Both Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck (H&NC)
Study ID: NCT00684385
Interventions
Study Description
Brief Summary: The purpose of this study is to provide ZD1839 for those patients with locally advanced and/or metastatic non-operable non-small cell lung cancer (stage III or IV) or recurrent and/or metastatic squamous cell head and neck cancer who receive the therapy on an expanded access basis due to their inability to meet eligibility criteria for on-going recruiting trials, inability to participate in other clinical trials (e.g., poor performance status, lack of geographic proximity), or because other medical interventions are not considered appropriate or acceptable.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, Berlin, , Germany
Research Site, Berlin, , Germany
Research Site, Berlin, , Germany
Research Site, Berlin, , Germany
Research Site, Essen, , Germany
Research Site, Frankfurt, , Germany
Research Site, Freiburg, , Germany
Research Site, Großhansdorf, , Germany
Research Site, Göttingen, , Germany
Research Site, Halle, , Germany
Research Site, Halle, , Germany
Research Site, Heidelberg, , Germany
Research Site, Kiel, , Germany
Research Site, Laatzen, , Germany
Research Site, Lemgo, , Germany
Research Site, Löwenstein, , Germany
Research Site, Mainz, , Germany
Research Site, München, , Germany
Research Site, Nürnberg, , Germany
Research Site, Oldenburg, , Germany
Research Site, Oldenburg, , Germany
Research Site, Stralsund, , Germany
Research Site, Stuttgart, , Germany
Research Site, Trier, , Germany
Research Site, Wiesbaden, , Germany
Research Site, Budapest, , Hungary
Research Site, Budapest, , Hungary
Research Site, Budapest, , Hungary
Research Site, Kecskemét, , Hungary
Research Site, Törökbálint, , Hungary
Research Site, Gdańsk, , Poland
Research Site, Warszawa, , Poland
Research Site, Zabrze, , Poland
Research Site, Newcastle-upon-Tyne, , United Kingdom
Contact Details
Name: Yuri Rukazenkov
Affiliation: AstraZeneca
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
